Back to search

Article

N6-methyladenosine modification of DYNLT1 Facilitates Tamoxifen Resistance in Luminal B Breast Cancer

2024-11-01

Abstract excerpt

<title>Abstract</title> <p>Purpose Resistance to tamoxifen poses a significant clinical challenge in the management of Luminal B breast cancer, necessitating the identification of novel biomarkers for predicting treatment response and prognosis. The specific role of DYNLT1 in endocrine response within Luminal B breast cancer remains uncertain. Methods The expression levels of DYNLT1 were assessed in breast canc...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
be1767e0-a127-53a4-89f4-507a394851e2
DOI
10.21203/rs.3.rs-5295457/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
N6-methyladenosine modification of DYNLT1 Facilitates Tamoxifen Resistance in Luminal B Breast CancerDOI 10.21203/rs.3.rs-5295457/v1
Select a neighboring publication to make it the new centre.